| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 144, Issue 7 2604-2608, Copyright © 1990 by American Association of Immunologists
ARTICLES |
S Schutze, S Nottrott, K Pfizenmaier and M Kronke
Clinical Research Group of the Max-Planck-Society, Gottingen, Federal Republic of Germany.
We have investigated the changes in protein kinase C (PKC) activity after treatment of several cell lines with TNF. Binding studies with [3H]phorbol dibutyrate (PBt2) on whole cells revealed rapid and transient activation of PKC in Jurkat, K562, and U937 cells with a maximum of phorbol ester binding at 6 min after TNF treatment. As shown by Scatchard analysis, the TNF-induced increase of [3H]PBt2 binding reflected increments of phorbol ester binding site numbers rather than greater binding affinities. Upon subfractionation of TNF-treated U937 cells a transient increase of PBt2 binding in the membrane fraction was accompanied by a long term loss of PBt2-binding in the cytosol, indicating a TNF-induced translocation of PKC from the cytosol to the cell membrane. With histone III-S as a substrate, the determination of specific PKC activity revealed similar kinetics of PKC translocation in U937 cells. TNF also induced PKC translocation in K562 and Jurkat cells. However, although TNF caused long term down-regulation of cytosolic PKC activity in U937 cells, the cytosolic PKC activity only transiently decreased in both Jurkat and K562 cells and then recovered to near basal levels. In the human nonmalignant fibroblast cell line CCD18, PKC was not activated by TNF. Our data suggest that PKC activation may play a major role in TNF signal transduction in some, but not all target cells.
This article has been cited by other articles:
|
|
 |
|
  C. Biagioni, F. Favilli, S. Catarzi, T. Marcucci, M. Fazi, F. Tonelli, M. T. Vincenzini, and T. Iantomasi Redox State and O2*- Production in Neutrophils of Crohn's Disease Patients Experimental Biology and Medicine, February 1, 2006; 231(2): 186 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rosenzweig, L. Braiman, A. Bak, A. Alt, T. Kuroki, and S. R. Sampson Differential Effects of Tumor Necrosis Factor-{alpha} on Protein Kinase C Isoforms {alpha} and {delta} Mediate Inhibition of Insulin Receptor Signaling Diabetes, June 1, 2002; 51(6): 1921 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Boussouar, R. Grataroli, J. Ji, and M. Benahmed Tumor Necrosis Factor-{alpha} Stimulates Lactate Dehydrogenase A Expression in Porcine Cultured Sertoli Cells: Mechanisms of Action Endocrinology, July 1, 1999; 140(7): 3054 - 3062. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Schutze, T. Machleidt, D. Adam, R. Schwandner, K. Wiegmann, M.-L. Kruse, M. Heinrich, M. Wickel, and M. Kronke Inhibition of Receptor Internalization by Monodansylcadaverine Selectively Blocks p55 Tumor Necrosis Factor Receptor Death Domain Signaling J. Biol. Chem., April 9, 1999; 274(15): 10203 - 10212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yucel-Lindberg, S. Nilsson, and T. Modeer Signal Transduction Pathways Involved in the Synergistic Stimulation of Prostaglandin Production by Interleukin-1{beta} and Tumor Necrosis Factor a in Human Gingival Fibroblasts Journal of Dental Research, January 1, 1999; 78(1): 61 - 68. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. May, C. P. D. Wheeler-Jones, R. A. Houliston, and J. D. Pearson Activation of p42mapk in human umbilical vein endothelial cells by interleukin-1alpha and tumor necrosis factor-alpha Am J Physiol Cell Physiol, March 1, 1998; 274(3): C789 - C798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Yorek, J. A. Dunlap, M. J. Thomas, P. R. Cammarata, C. Zhou, and W. L. Lowe Jr. Effect of TNF-alpha on SMIT mRNA levels and myo-inositol accumulation in cultured endothelial cells Am J Physiol Cell Physiol, January 1, 1998; 274(1): C58 - C71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Basu The Involvement of Novel Protein Kinase C Isozymes in Influencing Sensitivity of Breast Cancer MCF-7 Cells to Tumor Necrosis Factor-alpha Mol. Pharmacol., January 1, 1998; 53(1): 105 - 111. [Abstract] [Full Text]
|
|
|
|
|
|
A. Kalb, H. Bluethmann, M. W. Moore, and W. Lesslauer Tumor Necrosis Factor Receptors (Tnfr) in Mouse Fibroblasts Deficient in Tnfr1 or Tnfr2 are Signaling Competent and Activate the Mitogen-activated Protein Kinase Pathway with Differential Kinetics J. Biol. Chem., November 8, 1996; 271(45): 28097 - 28104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. W. Marino, J. D. Dunbar, L.-W. Wu, J. R. Ngaiza, H.-M. Han, D. Guo, M. Matsushita, A. C. Nairn, Y. Zhang, R. Kolesnick, et al. Inhibition of Tumor Necrosis Factor Signal Transduction in Endothelial Cells by Dimethylaminopurine J. Biol. Chem., November 8, 1996; 271(45): 28624 - 28629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kanety, R. Feinstein, M. Z. Papa, R. Hemi, and A. Karasik Tumor Necrosis Factor alpha-induced Phosphorylation of Insulin Receptor Substrate-1 (IRS-1) J. Biol. Chem., October 6, 1995; 270(40): 23780 - 23784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Obeid, C. Linardic, L. Karolak, and Y. Hannun Programmed cell death induced by ceramide Science, March 19, 1993; 259(5102): 1769 - 1771. [Abstract] [PDF]
|
|
|
|
|
|
J. Y. Lee, Y. A. Hannun, and L. M. Obeid Functional Dichotomy of Protein Kinase C (PKC) in Tumor Necrosis Factor-alpha (TNF-alpha ) Signal Transduction in L929 Cells. TRANSLOCATION AND INACTIVATION OF PKC BY TNF-alpha J. Biol. Chem., September 15, 2000; 275(38): 29290 - 29298. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
